Cargando…
Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
Despite decades of research very few vaccine-adjuvants have received FDA approval. Two fundamental challenges plague clinical translation of vaccine-adjuvants: reducing acute toxicities that result from systemic diffusion of many soluble adjuvants, and delivering multiple adjuvants at the same time...
Autores principales: | Madan-Lala, Ranjna, Pradhan, Pallab, Roy, Krishnendu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451393/ https://www.ncbi.nlm.nih.gov/pubmed/28566683 http://dx.doi.org/10.1038/s41598-017-02804-y |
Ejemplares similares
-
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015) -
Polymeric Core–Shell Combinatorial Nanomedicine
for Synergistic Anticancer Therapy
por: Shanavas, Asifkhan, et al.
Publicado: (2019) -
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
por: Atalis, Alexandra, et al.
Publicado: (2022) -
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021) -
Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection
por: Sia, Jonathan Kevin, et al.
Publicado: (2017)